Related references
Note: Only part of the references are listed.Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Pavlo Gilchuk et al.
IMMUNITY (2020)
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
Lucy Rutten et al.
CELL REPORTS (2020)
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
Linling He et al.
SCIENCE ADVANCES (2020)
Stabilized diverse HIV-1 envelope trimers for vaccine design
Qian Wang et al.
EMERGING MICROBES & INFECTIONS (2020)
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Jessica Marcandalli et al.
CELL (2019)
Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library
Faraz Shaikh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Early Human B Cell Response to Ebola Virus in Four US Survivors of Infection
Lauren E. Williamson et al.
JOURNAL OF VIROLOGY (2019)
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study
Martin R. Gaudinski et al.
LANCET (2019)
Pseudovirus rVSVΔG-ZEBOV-GP Infects Neurons in Retina and CNS, Causing Apoptosis and Neurodegeneration in Neonatal Mice
Ian L. McWilliams et al.
CELL REPORTS (2019)
Achieving cross-reactivity with pan-ebolavirus antibodies
Liam B. King et al.
CURRENT OPINION IN VIROLOGY (2019)
Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection
Carl W. Davis et al.
CELL (2019)
Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?
Michelle Meyer et al.
TRENDS IN MICROBIOLOGY (2019)
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal et al.
CELL REPORTS (2019)
Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
Liam B. King et al.
NATURE COMMUNICATIONS (2019)
Protein engineering and particulate display of B-cell epitopes to facilitate development of novel vaccines
Ziyang Xu et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination
Theodora U. J. Bruun et al.
ACS NANO (2018)
The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding
Liam B. King et al.
CELL HOST & MICROBE (2018)
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein
Pavlo Gilchuk et al.
IMMUNITY (2018)
Target Identification and Mode of Action of Four Chemically Divergent Drugs against Ebolavirus Infection
Jingshan Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Ebola: Lessons on Vaccine Development
Heinz Feldmann et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 72 (2018)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
Prevention of Ebola virus disease through vaccination: where we are in 2018
Yves Lévy et al.
LANCET (2018)
Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
Benjamin M. Janus et al.
NATURE COMMUNICATIONS (2018)
Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors
Natalia A. Kuzmina et al.
CELL REPORTS (2018)
Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers
Yoann Aldon et al.
CELL REPORTS (2018)
HIV-1 vaccine design through minimizing envelope metastability
Linling He et al.
SCIENCE ADVANCES (2018)
The quest for an antibody-based HIV vaccine
Barton F. Haynes et al.
IMMUNOLOGICAL REVIEWS (2017)
The HIV-1 envelope glycoprotein structure: nailing down a moving target
Andrew B. Ward et al.
IMMUNOLOGICAL REVIEWS (2017)
Native-like Env trimers as a platform for HIV-1 vaccine design
Rogier W. Sanders et al.
IMMUNOLOGICAL REVIEWS (2017)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2017)
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Ali Punjani et al.
NATURE METHODS (2017)
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia
S. B. Kennedy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Structural basis for antibody-mediated neutralization of Lassa virus
Kathryn M. Hastie et al.
SCIENCE (2017)
Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop
Chad E. Mire et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers
Charles D. Morris et al.
MBIO (2017)
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses
Anna Z. Wec et al.
CELL (2017)
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability
Xuelian Zhao et al.
CELL (2017)
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein
Zhen-Yong Keck et al.
JOURNAL OF VIROLOGY (2016)
Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic
William E. Diehl et al.
CELL (2016)
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
Andrew I. Flyak et al.
CELL (2016)
Antiviral therapeutics for the treatment of Ebola virus infection
Anthony P. Cardile et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Ebola virus disease candidate vaccines under evaluation in clinical trials
Karen A. Martins et al.
EXPERT REVIEW OF VACCINES (2016)
Toremifene interacts with and destabilizes the Ebola virus glycoprotein
Yuguang Zhao et al.
NATURE (2016)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Richard T. Davey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
K. Ewer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
Davide Corti et al.
SCIENCE (2016)
Accurate design of megadalton-scale two-component icosahedral protein complexes
Jacob B. Bale et al.
SCIENCE (2016)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
John Misasi et al.
SCIENCE (2016)
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak
Zachary A. Bornholdt et al.
SCIENCE (2016)
Feverish Quest for Ebola Immunotherapy: Straight or Cocktail?
Erica Ollmann Saphire et al.
TRENDS IN MICROBIOLOGY (2016)
Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
Zachary A. Bornholdt et al.
MBIO (2016)
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
Linling He et al.
NATURE COMMUNICATIONS (2016)
Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
Leopold Kong et al.
NATURE COMMUNICATIONS (2016)
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site
Katie A. Howell et al.
CELL REPORTS (2016)
Structures of Ebola virus GP and sGP in complex with therapeutic antibodies
Jesper Pallesen et al.
NATURE MICROBIOLOGY (2016)
Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
Andrew I. Flyak et al.
CELL (2015)
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
Pavel Pugach et al.
JOURNAL OF VIROLOGY (2015)
Human Ebola virus infection results in substantial immune activation
Anita K. McElroy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
Kwinten Sliepen et al.
RETROVIROLOGY (2015)
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
Marnie L. Fusco et al.
PLOS PATHOGENS (2015)
Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
Uzma N. Sarwar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
Andrea Marzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Jean-Philippe Julien et al.
SCIENCE (2013)
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Dmitry Lyumkis et al.
SCIENCE (2013)
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
Rogier W. Sanders et al.
PLOS PATHOGENS (2013)
Pathogenesis of the Viral Hemorrhagic Fevers
Slobodan Paessler et al.
Annual Review of Pathology-Mechanisms of Disease (2012)
Marburg Virus Glycoprotein GP2: pH-Dependent Stability of the Ectodomain α-Helical Bundle
Joseph S. Harrison et al.
BIOCHEMISTRY (2012)
Crystal Structure of the Marburg Virus GP2 Core Domain in Its Postfusion Conformation
Jayne F. Koellhoffer et al.
BIOCHEMISTRY (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A shared structural solution for neutralizing ebolaviruses
Joao M. Dias et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Molecular replacement with MOLREP
Alexei Vagin et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
The JCSG high-throughput structural biology pipeline
Marc-Andre Elsliger et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2010)
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
Laura M. Walker et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Martin F. Bachmann et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Ebolavirus glycoprotein structure and mechanism of entry
Jeffrey E. Lee et al.
FUTURE VIROLOGY (2009)
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2009)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme
Judith M. White et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Jeffrey E. Lee et al.
NATURE (2008)
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
Thomas W. Geisbert et al.
PLOS PATHOGENS (2008)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation
HS Yin et al.
NATURE (2006)
Automated molecular microscopy: The new Leginon system
C Suloway et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
REFMAC5 dictionary:: organization of prior chemical knowledge and guidelines for its use
AA Vagin et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Ectodomain shedding of the glycoprotein GP of Ebola virus
O Dolnik et al.
EMBO JOURNAL (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A graphical user interface to the CCP4 program suite
E Potterton et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: Implications for membrane fusion
J Liu et al.
BIOCHEMISTRY (2001)
Share Paper
